
A Potential New Approach for Treatment-Resistant Depression (TRD)
The Compass Pathfinder Study is a phase III clinical trial looking into a potential new approach for people with TRD using an investigational medicine called psilocybin, given with psychological support.
The study is suitable for people who have been diagnosed with major depression and are currently experiencing a recurrent or single episode of depression and have not responded to antidepressant treatment.
If you are interested in participating, please answer the questions below to determine if you qualify.
Watch this video to see how it works:
Hope Through Research
with the participation of

Am I a Candidate?
Answer the following questions to see if you may qualify: